These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4126074)

  • 1. Increased urinary fibrinogen derivatives after renal allotransplantation.
    Naish P; Peters DK; Shackman R
    Lancet; 1973 Jun; 1(7815):1280-2. PubMed ID: 4126074
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary fibrin-fibrinogen degradation products and acute renal-transplant rejection.
    Lameire N; Baele G; Hilderson J; Ringoir S
    Lancet; 1973 Jul; 2(7821):160-1. PubMed ID: 4124092
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of heterophile (sheep) haemagglutinins and fibrin-fibrinogen degradation products after renal transplantation and in proliferative glomerulonephritis.
    Hoq MS; Clarkson AR; Anderton JL; Cash JD
    Lancet; 1973 May; 1(7811):1029-31. PubMed ID: 4122111
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid latex-screening test for detection of fibrin-fibrinogen degradation products in urine after renal transplantation.
    Hulme B; Pitcher PM
    Lancet; 1973 Jan; 1(7793):6-8. PubMed ID: 4118584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinogen-fibrin degradation products in the urine. Measurement and characterization by means of electroimmunodiffusion (rapid method)].
    Thöni RF; Grob PJ
    Schweiz Med Wochenschr; 1973 Jul; 103(27):965-9. PubMed ID: 4146017
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinogen degradation products in the urine after kidney transplantation].
    Grob PJ; Thöni R; Scheitlin W
    Schweiz Med Wochenschr; 1971 Jun; 101(24):873-7. PubMed ID: 4947022
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial estimation of urinary fibrin fibrinogen degradation products in kidney transplantation.
    Hall CL; Pejhan N; Thomson RW; Dawson-Edwards P; Barnes AD; Robinson BH; Meynell MJ; Blainey JD
    Br Med J; 1973 Jul; 3(5873):204-7. PubMed ID: 4578136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F.D.P.
    Lancet; 1972 Nov; 2(7784):957-8. PubMed ID: 4116829
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis.
    Naish P; Evans DJ; Peters DK
    Br Med J; 1974 Mar; 1(5907):544-6. PubMed ID: 4593708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy.
    Hedner U
    Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological studies on the excretion of fibrinogen fragments in the urine of patients with kidney transplants as possible sign of a graft rejection].
    Zühlke V; Hermann G; Faul P
    Langenbecks Arch Chir; 1969; 325():725-31. PubMed ID: 4391980
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of determination of fibrin and fibrinogen degradation products].
    Czarniecki W
    Pol Arch Med Wewn; 1972 Feb; 49(2):159-69. PubMed ID: 4594950
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary FDP, heterophile agglutinins IgG, IgM, and C3 in renal homotransplant rejection and glomerulonephritis.
    Anderton JL; Hoq MS; Clarkson AR; Cash JD
    Proc Eur Dial Transplant Assoc; 1973; 10(0):500-7. PubMed ID: 4607330
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine.
    Morozumi K; Kano T; Kobayashi M; Shinmura I; Yoshida A; Fujinami T; Otaguro K; Uchida K; Yamada N; Tominaga Y
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1791-4. PubMed ID: 3547884
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of radioactive fibrinogen metabolism in renal allotransplantation (author's transl)].
    Akiyama T; Nagai N; Kaneko S; Matsuura T; Iguchi M; Kohri K; Minami K; Yachiku S; Kurita T; Sonoda T; Sagawa S; Usami M; Arima M; Ishibashi M
    Nihon Hinyokika Gakkai Zasshi; 1979 Jul; 70(7):810-4. PubMed ID: 388011
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravascular coagulation (IVC) in human renal allograft rejection.
    Busch GJ; Braun WE; Carpenter CB; Corson JM; Galvanek ER; Reynolds ES; Merrill JP; Dammin GJ
    Transplant Proc; 1969 Mar; 1(1):267-70. PubMed ID: 4944225
    [No Abstract]   [Full Text] [Related]  

  • 19. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M; Pandolfi M
    Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio-fibrinogen catabolism studies in human renal allograft recipients.
    Wardle EN; Uldall PR; Swinney JS
    Transplantation; 1974 Dec; 18(6):508-15. PubMed ID: 4612888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.